Total raised: $20.6M
Funding Rounds 1
| Date | Series | Amount | Investors |
| 08.01.2025 | Series A | $20.6M | - |
Mentions in press and media 2
| Date | Title | Description |
| 08.01.2025 | Neumirna Therapeutics Raises €20M in Series A Funding | Neumirna Therapeutics, a Copenhagen, Denmark-based RNA-focused biotech company, raised €20M in Series A funding. The round was led by Angelini Ventures and Invivo Partners with participation from Innovestor’s Life Science Fund and other exi... |
| - | Neumirna Therapeutics | “Neumirna Therapeutics Aps” |